2.3.3.10	(E,E)-11-(3-hydroxymethyl-4-oxo-2-oxytanyl)-3,5,7-trimethyl-2,4-undecadienoic acid	i.e. F-244	134965	
2.3.3.10	(E,E)-11-[3-(hydroxymethyl)-4-oxo-2-oxytanyl]-3,5,7-trimethyl-2,4-undecadienenoic acid	-	32767	
2.3.3.10	(S)-3-hydroxy-3-methylglutaryl-CoA	-	1835	
2.3.3.10	1-ethyl-3-(3-dimethylaminopropyl)carbodiimide	-	3174	
2.3.3.10	2-benzyl-9-(3,6-dioxocyclohexa-1,4-dienyl)-2,3,7,8-tetrahydro-6H-pyrido[1,2-a]pyrazine-1,4-dione	-	155381	
2.3.3.10	3,3-dimethylglutaryl-CoA	-	104724	
2.3.3.10	3-carboxy-2,2,5,5,-tetramethyl-1-pyrrolidinyloxyl-CoA	-	32798	
2.3.3.10	3-carboxypropionyl-CoA	-	48590	
2.3.3.10	3-chloropropionyl-CoA	-	15528	
2.3.3.10	3-hydroxy-3-methylglutaryl-CoA	-	1271	
2.3.3.10	3-oxohexanoyl-CoA	-	6444	
2.3.3.10	5,5'-dithiobis(2-nitrobenzoate)	residual activity 51%	303	
2.3.3.10	5,5'-dithiobis(2-nitrobenzoate)	Ellman's reagent	303	
2.3.3.10	5,5'-dithiobis(2-nitrobenzoate)	-	303	
2.3.3.10	acetoacetyl-CoA	substrate inhibition	187	
2.3.3.10	acetoacetyl-CoA	-	187	
2.3.3.10	acetoacetyl-CoA	competitive inhibition	187	
2.3.3.10	acetoacetyl-CoA	inhibition of wild-type enzyme, no inhibition of mutant enzyme H188N and H188N/S259A	187	
2.3.3.10	acetoacetyl-CoA	potent inhibitor of the overall reaction	187	
2.3.3.10	acetyloxy(phenyl)mercury	phenyl mercuric acetate	155380	
2.3.3.10	arsenite	in presence of CoA, residual activity 25%	397	
2.3.3.10	bromoacetyl-CoA	-	20167	
2.3.3.10	butyryl-CoA	-	270	
2.3.3.10	Cd2+	-	52	
2.3.3.10	CdSO4	residual activity 9%	4508	
2.3.3.10	Co2+	-	23	
2.3.3.10	CoA	-	18	
2.3.3.10	CoA	mixed product inhibition	18	
2.3.3.10	Cu2+	-	19	
2.3.3.10	decanoyl-CoA	-	541	
2.3.3.10	desulfo-CoA	-	1409	
2.3.3.10	diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate	disulfiram	155379	
2.3.3.10	DL-3-hydroxy-3-methylglutaryl-CoA	uncompetitive inhibition	4332	
2.3.3.10	DL-3-hydroxy-3-methylglutaryl-CoA	mixed product inhibition	4332	
2.3.3.10	DL-3-hydroxy-3-methylglutaryl-CoA	-	4332	
2.3.3.10	DL-3-hydroxy-3-methylglutaryl-CoA	product inhibition	4332	
2.3.3.10	DL-3-hydroxy-3-methylglutaryl-CoA	competitive inhibition	4332	
2.3.3.10	DL-3-methylglutaryl-CoA	-	50699	
2.3.3.10	F-244	IC50: 35 nM	56990	
2.3.3.10	F-244	-	56990	
2.3.3.10	F244	-	125121	
2.3.3.10	glutaryl-CoA	-	656	
2.3.3.10	heptanoyl-CoA	-	4253	
2.3.3.10	hexanoyl-CoA	-	395	
2.3.3.10	hymeglusin	IC50: 0.00032 mM, inhibitor binds to the thiol residue of Cys	13747	
2.3.3.10	hymeglusin	-	13747	
2.3.3.10	hymeglusin	i.e. (2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoic acid, time-dependent loss of activity is observed with more than 95% inhibition achieved at extended incubation times (10 min at 75-600 nM)	13747	
2.3.3.10	iodoacetamide	residual activity 84%	67	
2.3.3.10	iodoacetamide	-	67	
2.3.3.10	iodoacetate	-	93	
2.3.3.10	L-659,699	antibiotic 1233A	21911	
2.3.3.10	L-659,699	potent inhibitor of the recombinant enzyme	21911	
2.3.3.10	L-659,699	-	21911	
2.3.3.10	Lifibrol	-	45636	
2.3.3.10	methanol	-	83	
2.3.3.10	Mg2+	mitochondrial enzyme	6	
2.3.3.10	MgCl2	synthase I	196	
2.3.3.10	MgCl2	mitochondrial enzyme	196	
2.3.3.10	Mn2+	-	11	
2.3.3.10	additional information	desulfo-CoA protects against bromoacetyl-CoA inhibition, but not against p-chloromercuribenzoate and N-ethylmaleimide	2	
2.3.3.10	additional information	insensitive to feedback substrate inhibition by acetoacetyl-CoA	2	
2.3.3.10	N-ethylmaleimide	residual activity 46%	49	
2.3.3.10	N-ethylmaleimide	-	49	
2.3.3.10	NaAsO2	residual activity 90%	4035	
2.3.3.10	nonanoyl-CoA	-	6571	
2.3.3.10	octanoyl-CoA	-	385	
2.3.3.10	p-chloromercuribenzoate	residual activity 16%	43	
2.3.3.10	p-chloromercuribenzoate	-	43	
2.3.3.10	palmitoyl-CoA	mitochondrial synthase	128	
2.3.3.10	phenyl arsenious oxide	in presence of CoA, residual activity 41%; residual activity 75%	50363	
2.3.3.10	propionyl-CoA	-	350	
2.3.3.10	succinyl-CoA	mitochondrial synthase, 50% inhibition	224	
2.3.3.10	succinyl-CoA	-	224	
2.3.3.10	Zn2+	-	14